Created by a GI specialist, for GI specialists.
Founded by a gastroenterologist and veteran health tech leaders, the team at WovenX Health is deeply committed to solving the access challenges across specialty healthcare.

Our leadership team

Russ R. Arjal MD, AGAF
CMO & President, Co-Founder
Russ is a practicing gastroenterologist and serves on the Governing Board of the American Gastroenterological Association as the Development & Growth Councillor. He has worked at the intersection of private equity, tech innovation, and clinical gastroenterology, gaining a unique perspective on growth opportunities within the space.

Sheri Rudberg MBA, JD
CEO, Co-Founder
Sheri founded WovenX after experiencing firsthand the frustrations of navigating specialty care access for her family. With a background in strategy, law, and business operations, she has spent her career leading and scaling companies at the intersection of healthcare and innovation.

Nakort Valles
CTO, Co-Founder
Nakort is an accomplished technology leader with extensive experience in the healthcare technology sector. He has held significant roles in prior organizations, including Chief Technology Officer, Vice President of Engineering, and Director of Platform Engineering at MDLIVE, Inc. between November 2015 and May 2023.
Our advisors

Naresh Gunaratnam, MD, AGAF
Dr. Gunaratnam is a practicing gastroenterologist and former President and CEO of Huron Gastro Center for Digestive Care in Ann Arbor, Michigan. He serves on the governing board of the American Gastroenterological Association and is Vice President of the Digestive Health Physicians Association. He also co founded NovoLiver, an early stage company focused on reversing fatty liver disease. Dr. Gunaratnam has authored multiple publications on the use of telehealth in gastroenterology and completed his medical training at the University of Virginia, University of Connecticut, University of Michigan, and the Mayo Clinic.

Spencer Dorn, MD, MPH, MHA
Dr. Dorn is Vice Chair for Care Innovation and Professor of Medicine at the University of North Carolina at Chapel Hill. He leads care innovation efforts supporting more than 600 physicians and advanced practice providers while maintaining a clinical focus on disorders of gut brain interaction. Dr. Dorn has served as an investigator on clinical trials, co authored national practice guidelines, and previously led one of the nation’s premier academic gastroenterology practices. He completed his medical training at the University of Michigan, SUNY Brooklyn, Brigham and Women’s Hospital, and UNC.

Chad Ellimoottil, MD, MS
Dr. Ellimoottil is Medical Director of Virtual Care at the University of Michigan Medical Group, Principal Investigator of the Telehealth Research Incubator Lab, and Associate Professor of Urology at the University of Michigan. He oversees virtual care strategy across all specialties, supporting approximately 450,000 virtual visits annually, and leads federally funded research on telehealth’s impact on access, cost, and quality. His work is supported by the Agency for Healthcare Research and Quality. Dr. Ellimoottil has testified before the U.S. Senate Committee on Finance, was named one of HealthTech’s 30 Healthcare IT Influencers, and actively uses virtual care in his clinical urology practice.

Trey Lauderdale
Trey is an advisor, investor, and board member to multiple high growth, early stage technology companies. He previously founded and served as CEO of Voalte, growing the company from inception in 2008 to $40 million in annual revenue before its acquisition by Hillrom for $180 million. At Hillrom, Trey led the Care Communications business and was responsible for the company’s digital growth strategy until Hillrom’s $12 billion acquisition by Baxter in 2021. He holds a bachelor’s degree in Industrial Engineering and a master’s degree in Entrepreneurship from the University of Florida, where his team won the top prize in the Business Plan Competition prior to launching Voalte.